Exosomes as a therapeutic tool to promote neurorestoration and cognitive function in neurological conditions: Achieve two ends with a single effort
Solmaz Fallahi,Hamid Soltani Zangbar,Fereshteh Farajdokht,Reza Rahbarghazi,Gisou Mohaddes,Fariba Ghiasi
DOI: https://doi.org/10.1111/cns.14752
2024-05-24
CNS Neuroscience & Therapeutics
Abstract:Neurological diseases (including Alzheimer's disease, Parkinson's disease, stroke, multiple sclerosis, epilepsy, traumatic brain injury, encephalopathy, etc.) lead to an increase in inflammation, oxidative stress and cell death in the brain, but exosome therapy reverses the process by reducing inflammation and improving neurogenesis, and ultimately leads to cognitive function improvement. Exosomes possess a significant role in intercellular communications. In the nervous system, various neural cells release exosomes that not only own a role in intercellular communications but also eliminate the waste of cells, maintain the myelin sheath, facilitate neurogenesis, and specifically assist in normal cognitive function. In neurological conditions including Parkinson's disease (PD), Alzheimer's disease (AD), traumatic brain injury (TBI), and stroke, exosomal cargo like miRNAs take part in the sequela of conditions and serve as a diagnostic tool of neurological disorders, too. Exosomes are not only a diagnostic tool but also their inhibition or administration from various sources like mesenchymal stem cells and serum, which have shown a worthy potential to treat multiple neurological disorders. In addition to neurodegenerative manifestations, cognitive deficiencies are an integral part of neurological diseases, and applying exosomes in improving both aspects of these diseases has been promising. This review discusses the status of exosome therapy in improving neurorestorative and cognitive function following neurological disease.
pharmacology & pharmacy,neurosciences